The Fasting-Mimicking Diet: What Research Shows
The 5-day-a-month fasting-mimicking diet is a specific, clinically studied protocol, not general fasting. Here is what real human trials found, and the conflict of interest to know.

Once a month, for five days, you eat a specific, low-calorie, mostly-plant meal plan — then go back to eating normally for the other twenty-five. That’s the fasting-mimicking diet (FMD), a structured protocol designed by biogerontologist Valter Longo and tested in real, published human trials. It gets lumped in with intermittent fasting or a multi-day water fast, but it’s neither. It’s an engineered nutritional intervention with its own dedicated research literature, its own commercial product, and its own honest limitations worth understanding before you consider it.
What the Fasting-Mimicking Diet Actually Is
The FMD isn’t zero-calorie. It’s a five-day cycle with specific daily targets: around 1,090 calories on day one, then roughly 725 calories on days two through five, built from plant-based foods that are low in protein and sugar but relatively high in unsaturated fats like olives and nuts. The macronutrient mix is the point — it’s engineered to keep blood glucose, amino acids, and IGF-1 low enough to nudge the body toward some of the same cellular signaling seen in a true fast, without actually stopping food intake. It’s commercialized as a packaged kit called ProLon, though the underlying research is what matters here, not the branding.
What the Clinical Trial Data Actually Shows
The core human trial is a randomized study published in Science Translational Medicine in 2017. Researchers randomized 100 generally healthy adults: one arm ate normally for three months, the other completed three monthly five-day FMD cycles, with 71 completing the full protocol via a crossover design. After three cycles, the FMD group showed measurable drops in body weight, body fat, blood pressure, IGF-1, fasting glucose, C-reactive protein, and cholesterol. The honest caveat: these improvements were concentrated in people who started with elevated levels. If your blood pressure and IGF-1 are already normal, don’t expect a dramatic shift.
A Second Trial, and a Conflict of Interest Worth Knowing About
A 2023 randomized trial in npj Metabolic Health and Disease compared four monthly FMD cycles against a continuous Mediterranean diet in 84 people with obesity and hypertension. The FMD arm saw a statistically significant drop in HbA1c and a further reduction in IGF-1 that the Mediterranean diet arm didn’t match on those two specific markers, while the Mediterranean diet performed better on other markers like HDL cholesterol. In other words, this isn’t a case of one protocol beating the other across the board — it’s marker-specific and worth reading closely rather than summarizing as a clean win.
Here’s the part worth flagging plainly: that trial was sponsored by L-Nutra Inc., the company that sells the branded FMD kit, and Longo — the protocol’s inventor and a co-author on much of this research — holds an equity interest in L-Nutra. The paper’s disclosure states he did not participate in data collection or analysis, a standard mitigation step, but it’s still a real conflict worth factoring in the way you would for any industry-funded nutrition study. That doesn’t make the data wrong; it does mean it deserves the same scrutiny you’d give research funded by a company selling the product being studied.
How This Differs From Daily Fasting or a Longer Fast
Unlike the daily time-restricted eating covered in our guide to intermittent fasting after 40, the FMD isn’t a daily habit at all — it’s an occasional, structured five-day cycle done monthly or quarterly, with specific calorie and macronutrient targets for each day rather than just a shortened eating window. And unlike the extended true fasts discussed in our piece on autophagy and fasting, where most human evidence comes from multi-day water-only fasts, the FMD keeps some food coming in throughout. That makes it a more structured, more accessible entry point with its own dedicated trial literature — not simply a rebranded version of general fasting or autophagy research.
What You Can Actually Apply
- Don’t confuse FMD with daily fasting. If eating within a set daily window sounds more like what you’re after, our guide to intermittent fasting after 40 covers that approach — FMD is a once-a-month structured cycle, not a daily rhythm.
- Understand what fasting-like actually means here. The FMD is a specific low-protein, low-sugar, plant-based calorie reduction, not a true fast. For the biology behind real fasting and autophagy, see our breakdown of what happens when you don’t eat.
- Check your starting point before expecting results. Trial data shows the biggest benefits in people with already-elevated blood pressure, IGF-1, or cholesterol — if your baseline numbers are normal, don’t expect a dramatic shift.
- Read the conflict-of-interest line in any FMD study. The protocol’s inventor holds equity in the company selling the commercial kit; that’s worth weighing the same way you’d weigh claims in industry-funded research on things like NAD and aging supplements — useful data, but read with the funding source in view.
Want more science-backed breakdowns like this one? Subscribe to The Wonder Drop on YouTube for new videos every week.
This article is for informational purposes only and is not medical advice. See our Medical Disclaimer before changing your exercise, diet, or supplement routine.
See every method in action
New research-backed workouts on YouTube every week — no gym required.
Frequently asked questions
What exactly do you eat during a fasting-mimicking diet cycle?
A five-day, plant-based meal plan with specific calorie and macronutrient targets each day — roughly 1,090 calories on day one, then about 725 calories on days two through five, low in protein and sugar but higher in unsaturated fats such as olives and nuts. The goal is to keep blood sugar and IGF-1 low enough to trigger some fasting-like signaling while you are still eating actual food.
Is the fasting-mimicking diet the same thing as ProLon?
ProLon is the packaged commercial version of the protocol that Valter Longo's research group designed and studied, sold by the company L-Nutra. You could approximate similar macronutrient targets with whole foods on your own, though the published trials specifically tested the packaged version, so results with a homemade version haven't been directly studied in the same way.
Does the research prove the fasting-mimicking diet slows aging?
Not exactly. Published human trials show meaningful short-term improvements in markers linked to aging and disease risk, including blood pressure, IGF-1, fasting glucose, and inflammation markers like CRP, especially in people who started with elevated levels. That's different from proving a longer healthspan or lifespan in humans, which no study has directly measured yet.
Who should be cautious about trying a fasting-mimicking diet cycle?
Pregnant or breastfeeding people, anyone underweight or with a history of disordered eating, people on blood pressure or diabetes medication, and anyone managing a chronic illness should talk to a doctor first, since the calorie and macronutrient restriction can interact with medication dosing and existing conditions. The published trials also screened out several of these groups, so the safety data doesn't automatically extend to them.


